Tenet Healthcare Stock Soars 23% on Q2 Earnings Beat and Raised Outlook

Tenet Healthcare reported Q2 earnings that exceeded expectations, driving a 23% stock price increase. The company raised its full-year 2026 financial outlook, backed by hospital volume growth, improved high-acuity services, and expense management.

THC shares soared about 23% after the hospital operator reported Q2 2026 earnings of $6.12 per share, far above the ~$4.26 consensus, on revenue of $5.63 billion . Strong same-store hospital volume growth, higher-acuity services, tight expense discipline and continued strength in its ambulatory surgery business drove the beat .

Tenet raised its full-year 2026 outlook by roughly $295 million at the midpoint, lifting its EPS guidance to a $20.30 to $21.69 range from a prior consensus near $17.81 and boosting its adjusted EBITDA outlook . Major analyst firm UBS reiterated its support for the stock following the print.

The 23% single-session move reflects both the scale of the beat and the credibility the raised guidance lends to Tenet's shift toward higher-margin ambulatory care. Investors will watch whether same-store volume growth and expense discipline hold through the second half against healthcare-cost and reimbursement pressures.